☆ 4.8 Editorial Material

Long COVID: which symptoms can be attributed to SARS-CoV-2 infection?

LANCET (2022)

Get Full Text
Add to Collection

Journal

LANCET
Volume 400, Issue 10350, Pages 411-413

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/S0140-6736(22)01280-6

Keywords

-

Categories

Medicine, General & Internal

Funding

  1. GlaxoSmithKline
  2. AstraZeneca
  3. Boehringer Ingelheim
  4. Novartis
  5. Chiesi
  6. Genentech
  7. Roche
  8. Sanofi
  9. Regeneron
  10. Mologic
  11. 4DPharma
  12. National Institute for Health and Care Research (NIHR) [CS-2016-16-020]

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.